Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2024 Filed Apr 8, 2024 16:45 UTC |
Graves KurtDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042654 · ownership.xml · derivative · entry 1 Graves Kurt · CIK 0001406337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 20:45 UTC |
Dere Willard HDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042652 · ownership.xml · derivative · entry 1 Dere Willard H · CIK 0001311569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 20:45 UTC |
Ausiello Dennis ADirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042656 · ownership.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 16:45 UTC |
Kender Richard NDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042651 · ownership.xml · derivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 16:45 UTC |
Fraser ClaireDirector
|
GrantStock Option (right to buy · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042655 · ownership.xml · derivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 20:45 UTC |
Biondi PaulDirector
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0000950170-24-042657 · ownership.xml · derivative · entry 1 Biondi Paul · CIK 0001744508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-03 F1 · derivative.exercise_date: The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:20 UTC |
Thorell MarellaSee Remarks
|
GrantStock Options (right to buy) · Derivative | 700,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0000950170-24-037213 · ownership.xml · derivative · entry 1 Thorell Marella · CIK 0001826323 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2034-03-24 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 25, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
SaleCommon Stock | 4,400 | $1.08 | $4,752.00 |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · nonDerivative · entry 2 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,988 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 11, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
SaleCommon Stock | 3,939 | $1.08 | $4,254.12 |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · nonDerivative · entry 2 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,577 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
SaleCommon Stock | 3,939 | $1.08 | $4,254.12 |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · nonDerivative · entry 2 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,442 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
SaleCommon Stock | 11,549 | $1.08 | $12,472.92 |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · nonDerivative · entry 2 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,321 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.1101, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
SaleCommon Stock | 4,170 | $1.08 | $4,503.60 |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · nonDerivative · entry 2 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,436 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on April 13, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
SaleCommon Stock | 3,374 | $1.08 | $3,643.92 |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · nonDerivative · entry 2 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,705 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 5, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
SaleCommon Stock | 5,010 | $1.08 | $5,410.80 |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · nonDerivative · entry 2 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,856 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · derivative · entry 6 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 11,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
Exercise / conversionCommon Stock | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · nonDerivative · entry 1 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
Exercise / conversionRestricted Stock Units · Derivative | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · derivative · entry 6 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Underlying: Common Stock · 10,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
Exercise / conversionCommon Stock | 10,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · nonDerivative · entry 1 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · derivative · entry 6 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Underlying: Common Stock · 10,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
Exercise / conversionCommon Stock | 10,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · nonDerivative · entry 1 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · derivative · entry 6 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
Exercise / conversionCommon Stock | 31,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · nonDerivative · entry 1 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · derivative · entry 6 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
Exercise / conversionCommon Stock | 11,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · nonDerivative · entry 1 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · derivative · entry 6 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Underlying: Common Stock · 10,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
Exercise / conversionCommon Stock | 10,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · nonDerivative · entry 1 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · derivative · entry 6 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 11,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 15, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
Exercise / conversionCommon Stock | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · nonDerivative · entry 1 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
GrantRestricted Stock Units · Derivative | 35,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · derivative · entry 5 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 35,625 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · derivative · entry 4 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:21 UTC |
von Moltke LisaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 213,750 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016690 · ownership.xml · derivative · entry 3 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,750 Underlying: Common Stock · 213,750 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
GrantRestricted Stock Units · Derivative | 35,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · derivative · entry 5 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 35,625 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · derivative · entry 4 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:48 UTC |
DesRosier ThomasChief Legal Officer and EVP
|
GrantStock Option (Right to Buy) · Derivative | 213,750 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016712 · ownership.xml · derivative · entry 3 DesRosier Thomas · CIK 0001435744 · Chief Legal Officer and EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,750 Underlying: Common Stock · 213,750 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 35,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · derivative · entry 5 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 35,625 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · derivative · entry 4 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:13 UTC |
Arkowitz DavidChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 213,750 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016687 · ownership.xml · derivative · entry 3 Arkowitz David · CIK 0001296999 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,750 Underlying: Common Stock · 213,750 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
GrantRestricted Stock Units · Derivative | 106,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · derivative · entry 5 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,250 Underlying: Common Stock · 106,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 822,580 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · derivative · entry 4 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 822,580 Underlying: Common Stock · 822,580 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:42 UTC |
Shaff Eric D.Director · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 637,500 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016710 · ownership.xml · derivative · entry 3 Shaff Eric D. · CIK 0001643734 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 637,500 Underlying: Common Stock · 637,500 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
GrantRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · derivative · entry 5 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · derivative · entry 4 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:31 UTC |
Henn Matthew RSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 187,500 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016695 · ownership.xml · derivative · entry 3 Henn Matthew R. · CIK 0001767321 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
GrantRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · derivative · entry 5 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · derivative · entry 4 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:29 UTC |
Young Teresa L.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 187,500 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016694 · ownership.xml · derivative · entry 3 Young Teresa L. · CIK 0001814656 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
GrantRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · derivative · entry 5 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 287,905 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · derivative · entry 4 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,905 Underlying: Common Stock · 287,905 shares Expires 2034-02-13 F5 · derivative.exercise_date: The option will vest, if at all, in two substantially equal installments upon achievement of a 30-day trailing average public market closing price per share of the Issuer's common stock greater than or equal to $3.00 and $5.00, respectively. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 02:15 UTC |
Ege David S.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 187,500 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0000950170-24-016688 · ownership.xml · derivative · entry 3 Ege David S. · CIK 0001829360 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2034-02-13 F4 · derivative.exercise_date: The option will vest as to 25% of the shares on February 14, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter. Read SEC document |
| October 30, 2023 Filed Nov 1, 2023 01:36 UTC |
von Moltke LisaSee Remarks
|
SaleCommon Stock | 4,232 | $1.35 | $5,713.20 |
DisclosureSEC source: 0000899243-23-020070 · doc4.xml · nonDerivative · entry 2 von Moltke Lisa · CIK 0001808592 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,513 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on July 2, 2023, solely with the intent to cover taxes in connection with the vesting of the RSUs. F3 · price: The price reported in column 4 is a weighted average of the price. These shares were sold in multiple transactions at prices ranging from $1.3406 to $1.4115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.